We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$587M
AUM Growth
-$222M
Cap. Flow
-$5.15B
Cap. Flow %
-877.82%
Top 10 Hldgs %
35.65%
Holding
170
New
43
Increased
23
Reduced
46
Closed
45

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$19.7M
2
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$16.8M
3
BIIB icon
Biogen
BIIB
+$12.9M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.46M
5
ORA icon
Ormat Technologies
ORA
+$7.92M

Top Sells

Rank Stock Value
1
ISRL
Isramco Inc
ISRL
+$4.99B
2
MRK icon
Merck
MRK
+$24.8M
3
ABBV icon
AbbVie
ABBV
+$23.3M
4
AGN
Allergan Inc
AGN
+$23M
5
JNJ icon
Johnson & Johnson
JNJ
+$22.1M

Sector Composition

Rank Sector Weight
1 Healthcare 63.04%
2 Technology 5.1%
3 Industrials 3.71%
4 Energy 1.9%
5 Consumer Discretionary 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDUS
151
DELISTED
Radius Health, Inc.
RDUS
– –
-150,000
Closed -$3.15M
EPZM
152
DELISTED
Epizyme, Inc
EPZM
– –
-50,000
Closed -$1.36M
ARNA
153
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-50,000
Closed -$2.1M
XLRN
154
DELISTED
Acceleron Pharma
XLRN
– –
-100,000
Closed -$3.02M
IMMU
155
DELISTED
Immunomedics Inc
IMMU
– –
-534,050
Closed -$1.99M
TTPH
156
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
– –
-118
Closed -$47K
WINT
157
DELISTED
Windtree Therapeutics Inc
WINT
– –
-34,679
Closed -$893K
TLOG
158
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
– –
-194,200
Closed -$808K
MDAS
159
DELISTED
MEDASSETS INC COM STK (DE)
MDAS
– –
-433,889
Closed -$6.1M
SLXP
160
CALL
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
– –
-48,500
Closed -$7.58M
RNA
161
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
– –
-219,345
Closed -$1.85M
AUXL
162
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
– –
-1,000
Closed -$30K
AVNR
163
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
– –
-250,000
Closed -$2.98M
OMED
164
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
– –
-97,100
Closed -$1.84M
MCUR
165
DELISTED
Macrocure Ltd.
MCUR
– –
-7,100
Closed -$51K
AGN
166
DELISTED
Allergan Inc
AGN
– –
-128,840
Closed -$23M
3 4 5 6
7

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2014 Portfolio in Review

As of Q4 2014, Sphera Funds Management held 170 positions worth $587M, down 27% from $809M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Sphera Funds Management withdrew a net $5.15B in Q4 2014, closing 45 positions and reducing 46 holdings. Its most notable exit was Merck, an estimated $24.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 57% a quarter earlier, followed by Technology and Industrials.

Against the trend, Sphera Funds Management opened a new position in Gilead Sciences worth $17.9M.

  • Sphera Funds Management's largest Q4 2014 buy was Gilead Sciences: 190,000 shares worth $17.9M.
  • Sphera Funds Management added most to SALIX PHARMACEUTICALS LTD DEL in Q4 2014, an estimated $16.8M increase.
  • Sphera Funds Management's biggest Q4 2014 reduction was Isramco Inc, cutting an estimated $4.99B.
  • Sphera Funds Management fully exited Merck in Q4 2014, selling an estimated $24.8M.
  • Sphera Funds Management's ten largest holdings make up 36% of its $587M portfolio in Q4 2014.
  • Sphera Funds Management opened 43 new positions and closed 45 in Q4 2014.
  • Sphera Funds Management's portfolio value fell 27% quarter-over-quarter to $587M.

Based on Sphera Funds Management's 13F filing for Q4 2014, filed 12 Feb 2015.